Gene Expression Profiling for Prediction of Clinical Characteristics of Breast Cancer

Recent Progress in Hormone Research

Volumn 58, Issue , 2003, Pages 55-73

  Huang, Erich ^b   West, Mike ^b   Nevins, Joseph R ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; DOXORUBICIN; ESTROGEN; ESTROGEN RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 3; MESSENGER RNA; TRANSCRIPTION FACTOR E2F;

ANALYTIC METHOD; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CLASSIFICATION; CANCER SURVIVAL; CLINICAL FEATURE; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA MICROARRAY; FACTORIAL ANALYSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE TECHNOLOGY; HUMAN; HUMAN GENOME; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LEUKEMIA; LYMPH NODE METASTASIS; LYMPHOMA; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; METAGENE ANALYSIS; MOLECULAR MODEL; MUTATION; NONHUMAN; ONCOGENE NEU; PHENOTYPE; PREDICTION; PROBABILITY; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; RISK FACTOR; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VALIDATION PROCESS; BREAST TUMOR; GENETICS; PHYSIOLOGY;

BREAST NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; LYMPHATIC METASTASIS; PHENOTYPE; RECEPTORS, ESTROGEN;

EID: 0042809627     PISSN: 00799963     EISSN: None     Source Type: Journal    
DOI: 10.1210/rp.58.1.55     Document Type: Review

References (12)

1. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J, Lu L, Lewis DB, Tibshirani T, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM 2000 Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511
2. Ciocca DR, Fujimura FK, Tandon AK, Clark GM, Mark C, Lee Chen GJ, Pounds GJ, Vendely P, Owens MA, Pandian MR 1992 Correlation of HER-2/neu amplification with expression and with other prognostic factors in 1103 breast cancers. J Natl Cancer Inst 84:1279-1282
3. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES 1999 Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286:531-537
4. Hill AD, Tran KN, Akhurst T, Yeung H, Yeh SD, Rosen PP, Borgen PI, Cody HS 1999 Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 231:148-149
5. Kjaergaard J, Blichert-Toft M, Andersen JA, Rank F, Pedersen BV 1985 Probability of false negative nodal staging in conjunction with partial axillary dissection in breast cancer. Br J Surg 72:365-367
6. Muss HB, Thor AD, Berry DA, Kute T, Liu ET, Koerner F, Cirrincione CT, Budman DR, Wood WC, Barcos M 1994 c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med 331:211
7. Shek LL, Godolphin W 1988 Model for breast cancer survival: relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration, and tumor necrosis. Cancer Res 48:5565-5569
8. Southern E 1975 Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503-517
9. Spang R, Zuzan H, West M, Nevins JR, Blanchette C, Marks J 2003 Prediction and uncertainty in the analysis of gene expression profiles. Silico Biol, in press
10. Tandon AK, Clark GM, Chamness GC, Ullrich A, McGuire WL 1989 HER-2/neu oncogene protein and prognosis in breast cancer. J Clin Oncol 7:1120-1128
11. West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, Zuzan H, Olson JA Jr, Marks JR, Nevins JR 2001 Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 98:11462-11467
12. West M 2003 Bayesian factor regression models in the "large p, small n" paradigm. Bayesian Statistics, in press